IRIS
PIERONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.689
AS - Asia 2.321
EU - Europa 1.622
SA - Sud America 385
AF - Africa 129
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.632
SG - Singapore 927
CN - Cina 727
IT - Italia 358
BR - Brasile 312
IE - Irlanda 296
SE - Svezia 232
HK - Hong Kong 197
DE - Germania 156
FI - Finlandia 151
VN - Vietnam 137
TR - Turchia 112
NL - Olanda 92
ZA - Sudafrica 82
RU - Federazione Russa 62
GB - Regno Unito 57
AT - Austria 50
IN - India 46
KR - Corea 35
FR - Francia 31
AR - Argentina 30
CI - Costa d'Avorio 28
BE - Belgio 24
CA - Canada 24
ID - Indonesia 24
MX - Messico 23
PL - Polonia 21
JP - Giappone 20
CZ - Repubblica Ceca 19
ES - Italia 15
BD - Bangladesh 14
IQ - Iraq 14
PK - Pakistan 14
CO - Colombia 12
LU - Lussemburgo 12
LT - Lituania 11
EC - Ecuador 10
UZ - Uzbekistan 9
SA - Arabia Saudita 8
UA - Ucraina 8
AE - Emirati Arabi Uniti 6
EG - Egitto 5
MA - Marocco 5
PY - Paraguay 5
VE - Venezuela 5
AU - Australia 4
BO - Bolivia 4
CH - Svizzera 4
IL - Israele 4
KG - Kirghizistan 4
AZ - Azerbaigian 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
TW - Taiwan 3
CL - Cile 2
DZ - Algeria 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 7.153
Salva come PNG Salva come JPEG
Città #
Singapore 507
Ashburn 377
Chandler 339
Dublin 294
Dallas 254
Santa Clara 203
Hong Kong 194
Beijing 160
Ann Arbor 146
Parma 109
Boardman 91
Johannesburg 76
Shanghai 73
Dearborn 72
Izmir 72
Los Angeles 66
Munich 63
Nanjing 61
Hefei 59
Princeton 57
Ho Chi Minh City 55
Helsinki 54
Columbus 46
New York 43
Wilmington 43
Bremen 40
Vienna 37
Chicago 32
Moscow 30
Turku 30
Hanoi 29
Abidjan 28
São Paulo 28
The Dalles 28
Bologna 24
Guangzhou 23
Seoul 23
Kocaeli 21
Council Bluffs 19
Warsaw 19
Jakarta 18
San Mateo 18
Shenyang 18
Tokyo 18
Brooklyn 17
London 17
Nanchang 17
Seattle 17
Atlanta 16
Brussels 16
Falls Church 16
Hebei 16
Houston 15
Milan 15
Buffalo 14
Changsha 14
Jinan 13
Brno 12
Jiaxing 12
Norwalk 12
San Jose 12
Brasília 11
Chennai 11
Frankfurt am Main 11
Orem 11
Haiphong 9
Nuremberg 9
Des Moines 8
Fremont 8
Istanbul 8
Luxembourg 8
Rio de Janeiro 8
Amsterdam 7
Curitiba 7
Denver 7
Florence 7
Manchester 7
Montreal 7
Phoenix 7
Porto Alegre 7
Stockholm 7
Tianjin 7
Belo Horizonte 6
Bengaluru 6
Dalmine 6
Modena 6
Mumbai 6
Poplar 6
Quito 6
Rome 6
Sassari 6
Shijiazhuang 6
Tashkent 6
Woodbridge 6
Ankara 5
Aracaju 5
Baghdad 5
Birmingham 5
Boston 5
Cairo 5
Totale 4.522
Salva come PNG Salva come JPEG
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 229
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 181
Nuovi composti antimicrobici 177
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 170
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 158
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 157
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 157
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 155
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 151
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 148
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 144
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 138
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 137
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 137
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 136
Towards the sustainable discovery and development of new antibiotics 134
Antituberculosis agents: Beyond medicinal chemistry rules 133
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 133
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 132
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 130
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 129
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 125
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 124
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 124
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 122
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 122
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 120
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 119
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 117
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 113
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 113
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 113
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 108
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 106
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 105
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 104
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 104
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 102
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 101
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 101
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 98
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 97
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 97
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 95
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 93
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 92
Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes 85
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 85
Quorum sensing inhibitors (QSIs): a patent review (2019–2023) 82
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 80
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 75
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 75
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 73
Indoleamides are active against drug-resistant mycobacterium tuberculosis 72
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 66
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 65
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 61
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 61
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 59
Spectinamides: A challenge, a proof, and a suggestion 58
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 58
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 58
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 56
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 54
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 54
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 51
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 47
Benzotriazole derivatives as alternate O-acetylserine sulfhydrylase substrates to impair cysteine biosynthesis in Gram-negative bacteria 32
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype 26
Totale 7.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.989
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 0 12 8 24 46 41 17 21
2021/2022379 15 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/20251.751 64 90 144 95 151 221 109 69 155 163 195 295
2025/20262.404 414 357 554 359 563 157 0 0 0 0 0 0
Totale 7.314